What's Happening?
Galderma has announced the launch of ALASTIN Signature Practices, a new initiative aimed at dermatology, plastic surgery, and medical aesthetics practices across the United States. This program integrates ALASTIN's regenerative skincare portfolio into
treatment planning and patient care, starting with the Colorado Springs Dermatology Clinic as the first designated practice. The initiative is designed to offer a comprehensive range of products that reflect ALASTIN's differentiated regenerative science and peri-procedural skincare regimens. The program includes advanced education, consistent skincare integration, and procedure-connected regimens to support a cohesive peri-procedural skincare experience. Additional practices are expected to join throughout 2026.
Why It's Important?
The introduction of ALASTIN Signature Practices is significant for the U.S. dermatology and aesthetics industry as it represents a shift towards more integrated and science-backed skincare solutions. By aligning skincare with procedural workflows, these practices aim to enhance patient outcomes and satisfaction. This initiative could lead to increased adoption of regenerative skincare products, potentially driving growth in the dermatology market. It also underscores the importance of collaboration between skincare brands and medical professionals to deliver comprehensive patient care.
What's Next?
Galderma plans to expand the ALASTIN Signature Practices program across key U.S. markets throughout 2026. Practices interested in participating can connect with ALASTIN representatives to learn about the criteria and steps for qualification. This expansion is likely to foster further collaboration between skincare providers and medical aesthetics practices, potentially leading to new innovations in regenerative skincare.
